EUVIMEDEUVIMED entdecken
LeserbriefOpen Access

Targeted Therapy of CAR+ T-Cell Lymphoma after Anti-BCMA CAR T-Cell Therapy

Adolfo Aleman, Oliver Van Oekelen iD, David T Melnekoff, Leah Grossman, Tarek H Mouhieddine iD, Agata Kurowski, Ivan Odak, Sidorela Reci, Shriya Desai iD, Shannon Meledathu, Malini P Naidu, Ravi P Shukla und 23 weitere

New England Journal of Medicine · 21.08.2025 · 393 (8) · 823-825

DOI: 10.1056/nejmc2504588 ↗

Kurz gefasst

Leserbrief in der Zeitschrift New England Journal of Medicine, erschienen am 21.08.2025. Verfasst von Adolfo Aleman und 34 weiteren Autor:innen. Beteiligte Einrichtung: Icahn School of Medicine at Mount Sinai, New York. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 5 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, American Society of Hematology, NCATS NIH HHS.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Icahn School of Medicine at Mount Sinai, New York.

ORCID-Profile: Oliver Van Oekelen, Tarek H Mouhieddine, Shriya Desai

Förderung

  • NCI NIH HHS
  • American Society of Hematology
  • NCATS NIH HHS
  • NHLBI NIH HHS
  • National Center for Advancing Translational Sciences
  • Multiple Myeloma Research Foundation
  • National Heart, Lung, and Blood Institute
  • National Cancer Institute

Zitieren

APA

Aleman, A., Van Oekelen, O., Melnekoff, D. T., Grossman, L., Mouhieddine, T. H., Kurowski, A., Odak, I., Reci, S., Desai, S., Meledathu, S., Naidu, M. P., Shukla, R. P., Dutta, R. P., Kappes, K., Serebryakova, K., Jackson, H., Lu, J., Chatikhine, A., Kulkarni, R., …, & Parekh, S. (2025). Targeted Therapy of CAR+ T-Cell Lymphoma after Anti-BCMA CAR T-Cell Therapy. New England Journal of Medicine, 393(8), 823-825. https://doi.org/10.1056/nejmc2504588

Vancouver

Aleman A, Van Oekelen O, Melnekoff DT, Grossman L, Mouhieddine TH, Kurowski A, et al. Targeted Therapy of CAR+ T-Cell Lymphoma after Anti-BCMA CAR T-Cell Therapy. New England Journal of Medicine. 2025;393(8):823-825. doi:10.1056/nejmc2504588

BibTeX
@article{Aleman2025,
  author = {Aleman, Adolfo and Van Oekelen, Oliver and Melnekoff, David T and Grossman, Leah and Mouhieddine, Tarek H and Kurowski, Agata and Odak, Ivan and Reci, Sidorela and Desai, Shriya and Meledathu, Shannon and Naidu, Malini P and Shukla, Ravi P and Dutta, Rudra P and Kappes, Katerina and Serebryakova, Kseniya and Jackson, Hayley and Lu, Jordan and Chatikhine, Anastasia and Kulkarni, Raksha and Moinfar, Zahra and Croken, Matthew M and Mehrotra, Meenakshi and Baskovich, Brett and Rayamajhi, Sampanna and Richard, Shambavi and Rossi, Adriana C and Salib, Christian and Houldsworth, Jane and Brown, Brian D and Merad, Miriam and Laganà, Alessandro and Brunner, Patrick M and Jagannath, Sundar and Brody, Joshua D and Parekh, Samir},
  title = {Targeted Therapy of CAR+ T-Cell Lymphoma after Anti-BCMA CAR T-Cell Therapy},
  journal = {New England Journal of Medicine},
  year = {2025},
  volume = {393},
  number = {8},
  pages = {823--825},
  doi = {10.1056/nejmc2504588}
}
Kostenlos starten →